Skip to main content
Equibles
MBX logo

MBX · MBX Biosciences, Inc. · Proposed Sales

Track MBX — free

Use MBX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MBX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$55.94 +1.43 (+2.62%) At close · Nov 13 Play latest call Q2 2025 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$2.78B
Shares
49.66M
Volume · Nov 13 855.51K Avg daily vol (3M) 527.3K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-11-10 Hoerter Steven L. 4,893
2026-11-04 Azoulay Salomon 373
2026-08-17 Hawryluk P. Kent 3,745
2026-08-04 Azoulay Salomon 370
2026-08-04 Hawryluk P. Kent 936
2026-06-10 Bartram Richard 9,167
2026-06-09 Bartram Richard 10,833
2026-05-13 Bartram Richard 15,000
2026-05-11 Bartram Richard 22,500
2026-05-08 Azoulay Salomon 70,003
2026-05-08 Bartram Richard 10,000
2026-05-07 Bartram Richard 10,000
2026-05-06 Hawryluk P. Kent 607
2026-05-06 Azoulay Salomon 231
2026-05-01 Bartram Richard 5,000
2026-04-22 Bartram Richard 10,423
2026-03-25 Bartram Richard 1,061
2026-03-16 Bartram Richard 10,000
2026-01-12 CORNELIUS JAMES M 30,864
Showing 1–19 of 19 filings
Key facts CIK 1776111 CUSIP 55287L101 13F (30d) 126 filings 122 filers Visit website Investor relations